MedPath

Early Endoscopic Ultrasound - Based Sphincterotomy or Conservative Treatment in Severe Biliary Pancreatitis

Not Applicable
Terminated
Conditions
Pancreatitis Acute Biliary
Registration Number
NCT00987428
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The primary purpose of this trial is to determine whether an early Early Endoscopic Ultrasound (EUS) immediately followed by an endoscopic sphincterotomy (ES) in case of bile duct stones may improve outcomes in patients with predicted severe acute biliary pancreatitis (ABP).

Detailed Description

The management of Acute biliary pancreatitis (ABP) remains controversial. Although early decompression of the bile duct is deemed potentially beneficial, previous randomised studies failed to show the benefit of early endoscopic sphincterotomy (ES) except in selected cases. However, those studies did not use recent non invasive diagnostic methods such as EUS.

Methodology: Patients in the study group undergo EUS followed by ES in case of common bile duct stones within 48 hours of the onset pf symptoms; The control group includes patients with predicted severe ABP undergoing conservative treatment or endoscopic sphincterotomy (without EUS) within 72 hours of the onset of symptoms in case of cholangitis or biliary obstruction.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
27
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The difference between the SOFA score measured at entry in the study (day 0) and at day 8Day 8
Secondary Outcome Measures
NameTimeMethod
Differences in SOFA score as measured at entry in the study and at day 15Day 15
Procedure-related morbidityat Day 15 to 3 months
Overall morbidityat day 15
Overall mortalityat day 15
Difference in Balthazar's scores (CT-scan) at entry and at days 8 and 15at day 8 and day 15

Trial Locations

Locations (1)

Hopital Cochin

🇫🇷

Paris, France

Hopital Cochin
🇫🇷Paris, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.